This content requires Adobe Flash Player version
Either you do not have Adobe Flash Player installed,
or your version is too old,
or there is a problem with your Flash installation and we were unable to detect it.
required. Clinical response to antibiotic therapy is not always dependent on bacterial sensitivity.
A minimum of 10 to 14 days’ treatment is recommended
Intravenous antibiotics for BCC
An aminoglycoside (Tobramycin), combined with a beta lactam (Aztreonam, Ceftazidime, Meropenem or Piperacillin–Tazobactam) are used in the treatment pulmonary exacerbations. Triple therapy using agents such as Tobramycin, Meropenem and Ceftazidime are prescribed in patients who fail to respond to dual therapy. A minimum of 10 to 14 days’ treatment is recommended.